CRL

314.3104.15%
NC

Nancy C. Andrews

Independent Director

Dr. Nancy C. Andrews, Ph.D., M.D., is Home Secretary of National Academy of Sciences. Dr. Andrews is Director of Novartis International AG from 2015. Dr. Andrews serves as Executive Vice President and Chief Scientific Officer at Boston Children Hospital since December 20, 2021. Dr. Andrews has been an Independent Director at Charles River Laboratories International, Inc. since February 28, 2020. Dr. Andrew has been an Independent Non-Executive Director of Novartis International AG since February 27, 2015. Dr. Andrews serves as Director at Novartis AG since 2015. She was previously at Duke University from October 2007 to December 2021, where she served as Dean of the School of Medicine, Vice Chancellor for Academic Affairs, Professor of Pediatrics and Professor of Pharmacology & Cancer Biology. Prior to joining Duke, she served as Director of the Harvard-MIT M.D.-Ph.D. program and was dean for basic sciences and graduate studies and professor of pediatrics at the Harvard Medical School since 1999 until 2003. She served as the George Richards Minot Professor of Pediatrics at the Harvard Medical School. From 1993 to 2006, Dr. Andrews was a biomedical research investigator at the Howard Hughes Medical Institute. She maintains a research laboratory funded by the US National Institutes of Health, studying iron homeostasis and mouse models of human diseases. She is the Council Member of National Academy of Sciences, US. She was council Member from 2013 to 2019 and Member of National Academy of Medicine, US,where she serves as Home Secretary. Her research expertise is in iron homeostasis and mouse models of human diseases. She had been a Director of Maze Therapeutics, Inc. since January 2021 and serves as its Independent Non-Employee Director. Dr. Andrews served as Chairman of the Board of Directors of the Burroughs Wellcome Fund from 2011 to 2019 and serves as its member. From 1999 to 2003, Dr. Andrews served as Member of the Massachusetts Institute of Technology (MIT) Corporation M.D./Ph.D. Program and the principal investigator of its MSTP grant. Dr. Andrews served as President of the American Society of Clinical Investigation. She was elected as a Fellow of the American Association for the Advancement of Science and to membership of both the Institute of Medicine of the National Academies and the American Academy of Arts and Sciences. Since July 2018, She serves on the Scientific Advisory Board of Dyne Therapeutics Inc. Dr. Andrews serves as Chairman of Board of Directors of the American Academy of Arts and Sciences. She served on the Council of the Institute of Medicine and on the Scientific Management Review Board of the National Institutes of Health, US (2014–2019). She completed her residency and fellowship trainings in pediatrics and hematology/oncology at the Children’s Hospital in Boston and the Dana-Farber Cancer Institute, both in the United States and served as an attending physician at the Children’s Hospital, Boston. She received B.S. and M.S. degrees in Molecular Biophysics and Biochemistry from Yale University. Dr. Andrews received her Ph.D. in biology from the Massachusetts Institute of Technology in 1985 and her M.D. from the Harvard Medical School in 1987.

Positions